ScripsAmerica Announces Resignation of Rober

ScripsAmerica Announces Resignation of Robert Schneiderman as Company's President and CEO
.TYSONS CORNER, Va., July 7, 2015 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (SCRC) today announced that its Board of Directors has accepted the resignation of Robert "Bob" Schneiderman as the Company's President, Chief Executive Officer (CEO) and Board member, effective July 1, 2015.

ScripsAmerica has designated current Chairman of the Board, Brian Ettinger as Interim CEO and Director of Business Development, Adam Brosius as Interim President. According to the Company, its Board of Directors will consider Mr. Brosius as a permanent candidate for these executive management positions when it conducts a search for ScripsAmerica's new CEO and President. The executive search will begin immediately and the Company estimates it will be complete before December 31, 2015.

"ScripsAmerica would like to thank Mr. Schneiderman for his years of dedicated service and leadership of our company and wish him the best in his future endeavors. As one of its founding members, Bob led ScripsAmerica to success in the healthcare industry by growing and adapting our core business while also taking it from a privately held company to a publicly traded corporation," commented Interim CEO, Brian Ettinger.

"Moving forward, ScripsAmerica is excited to welcome new leadership as the Company continues working diligently to increase revenues and shareholder value, primarily by expanding our specialty pharmacy operations while significantly reducing our expenses. We would also like to thank our shareholders for their patience regarding the Company's audited financials, which we anticipate will be complete in the near future," added Ettinger



/finance.yahoo.com/news/scripsamerica-announces-resignation-robert-schneiderman-120000822.html